Intellipharmaceutics International
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Intellipharmaceutics International's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 95% to $65,728. The net income raised on -$2,892,394 and profit margin reached -4401%. Total operating expenses were $2,916,235.
Profit Margin
| 2012 | 107.09K | -6.13M | -5730.51% |
|---|---|---|---|
| 2013 | 1.52M | -11.49M | -752.55% |
| 2016 | 2.24M | -10.14M | -451.43% |
| 2019 | 1.40M | -3.39M | -241.95% |
| 2022 | 65.72K | -2.89M | -4400.55% |
IPCIF Income Statement (2013 – 2023)
| 2023 | 2020 | 2017 | 2014 | 2013 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 65.72K | 1.40M | 2.24M | 1.52M | 107.09K |
Cost of revenue | 0 | 33.06K | 8.16M | 5.07M | 5.99M |
Gross profit | 65.72K | 1.36M | -5.91M | -3.54M | -5.88M |
Operating exp. | |||||
Research and development | 2.14M | 3.51M | 8.16M | 5.07B | 107.09M |
Selling and marketing | 0 | 0 | 0 | 388.88K | 0 |
Total operating expenses | 2.91M | 6.07M | 3.93M | 3.26M | 4.12M |
Operating income | -2.85M | -4.67M | -9.85M | -6.81M | -10.11M |
Other income (expenses), net | 255.06K | 1.32M | -22.47K | -4.24M | 3.91M |
Income before tax | -2.88M | -3.35M | -10.14M | -11.49M | -4.88M |
Income tax expense | 5.33K | 32.83K | 270.23K | 6.13M | 4.88M |
Net income | -2.89M | -3.39M | -10.14M | -11.49M | -6.13M |
Earnings per share | |||||
Basic EPS | -0.08 | -0.16 | -3.8 | -5.84 | -3.56 |
Diluted EPS | -0.08 | -0.16 | -3.8 | -5.84 | -3.56 |
| Data source | Data source | Data source | Data source |